Use within the supplier-stated beyond-use window
The peptide market has exploded with options and with that growth has come a wide range of quality, transparency, and marketing claims that can make it genuinely difficult to figure out what you're actually getting
This is a question that comes up frequently, and it deserves a nuanced answer
Nephrology and oncology practices frequently have D63.1 and D63.8 sequencing errors that cost significant HCC revenue annually
The risk profile changes significantly with unregulated products, inappropriate dosing, or unsupervised administration - contexts that are unfortunately common in this space
Side Effects and Risks The most common tesamorelin side effects are injection-site reactions, joint pain, muscle pain, swelling, and redness (FDA, 2025)